![headshot](/-/media/assets/amerisourcebergen/lung-i_cheng-2023.jpg?h=450&iar=0&w=450&useCustomFunctions=1¢erCrop=1&hash=8E33C7720CCF481B04BF2A6B223AA264)
Lung-I Cheng
Vice President, Cell and Gene Therapy
Biopharma Services
AmerisourceBergen
Lung-I Cheng is Vice President, Cell and Gene Therapy, leading AmerisourceBergen’s Cell and Gene Therapy (CGT) service line within Commercial Solutions.
He is responsible for leading a unified CGT go-to-market strategy that addresses external customer needs, and provides integrated solutions that deliver the right resources at the right time to position therapies for success.
Before joining AmerisourceBergen, he spent a decade in biopharma and most recently led Takeda Oncology’s global value and access team in cell therapies and pipeline.